Amniox Medical's NEOX® And CLARIX® Product Lines Receive American Podiatric Medical Association (APMA) Seal Of Approval

ATLANTA--(BUSINESS WIRE)--Amniox Medical, Inc., a developer and marketer of restorative therapies processed from amniotic membrane and umbilical cord, announces that it was granted the American Podiatric Medical Association (APMA) Seal of Approval for its NEOX Wound Matrix and CLARIX Regenerative Matrix product lines.

As part of its mission, APMA strives to provide reliable information about the quality and effectiveness of available products and therapies to clinicians and patients. The APMA Seal of Approval is granted to products found to promote good foot health.

Help employers find you! Check out all the jobs and post your resume.